Page last updated: 2024-09-04

beta-lactams and Bronchiectasis

beta-lactams has been researched along with Bronchiectasis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Alispahic, IA; Andreassen, HF; Armbruster, K; Bangsborg, J; Bodtger, U; Browatzki, A; Christensen, CW; Coia, JE; Datcu, R; Eklöf, J; Ellingsgaard, T; Fenlev, CS; Ghathian, KSA; Gundersen, L; Harboe, ZB; Heidemann, M; Janner, J; Jensen, JUS; Jensen, TT; Johansson, SL; Johnsen, S; Kjærgaard, JL; Lapperre, TS; Linde, H; Moberg, M; Nielsen, TL; Overgaard, RH; Pedersen, L; Rosenvinge, FS; Saeed, MI; Seersholm, N; Sivapalan, P; Sørensen, VM; Titlestad, I; Ulrik, CS; Vijdea, R; Weinreich, UM; Wilcke, T; Østergaard, C1
Felix, LM; Kaehne, A; Marsden, PA; Milan, SJ; Sheridan, E; Spencer, S1
Falagas, ME; Trigkidis, KK; Vardakas, KZ1
Homma, JY; Iki, Y; Inatomi, K; Kasai, T; Kunii, O; Mashimo, K; Nishimura, Y; Shimada, K; Takigami, T; Tanimoto, H1

Reviews

2 review(s) available for beta-lactams and Bronchiectasis

ArticleYear
Head-to-head trials of antibiotics for bronchiectasis.
    The Cochrane database of systematic reviews, 2018, Sep-05, Volume: 9

    Topics: Adult; Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Bronchiectasis; Child; Fluoroquinolones; Forced Expiratory Volume; Humans; Polymyxins; Pseudomonas Infections; Randomized Controlled Trials as Topic

2018
Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:3

    Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchiectasis; Cystic Fibrosis; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Quinolones; Respiratory Tract Infections; Treatment Outcome

2015

Trials

1 trial(s) available for beta-lactams and Bronchiectasis

ArticleYear
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma?
    Trials, 2022, Sep-27, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; Asthma; beta-Lactams; Bronchiectasis; Ciprofloxacin; Fibrosis; Humans; Prednisolone; Prognosis; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive

2022

Other Studies

1 other study(ies) available for beta-lactams and Bronchiectasis

ArticleYear
Combination therapy using 9,3"-di-O-acetyl-midecamycin with beta-lactam antibiotics against Pseudomonas aeruginosa infection.
    The Japanese journal of experimental medicine, 1981, Volume: 51, Issue:5

    Topics: Adult; Agammaglobulinemia; Aged; Anti-Bacterial Agents; beta-Lactams; Bronchiectasis; Bronchitis; Drug Therapy, Combination; Female; Humans; Leucomycins; Male; Middle Aged; Miocamycin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Emphysema; Urinary Bladder, Neurogenic

1981